Epithelial Neoplasms of the Stomach

Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas

Volumn , Issue , 2009, Pages 563-579

  Lauwers, Gregory Y ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882892080     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604059-0.50024-2     Document Type: Chapter

References (242)

1. Fenoglio-Preiser C, Carneiro F, Correa P, et al. Tumours of the stomach. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System 2000, 37-948. IARC Press, Lyon, France. S.R. Hamilton, L.A. Aaltonen (Eds.).
2. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics, 2001. CA Cancer J Clin 2001, 51:15-36.
3. Reid-Lombardo KM, Gay G, Patel-Parekh L, et al. Treatment of gastric adenocarcinoma may differ among hospital types in the United States: A report from the National Cancer Data Base. J Gastrointest Surg 2007, 11:410-419. discussion 419-420.
4. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265:1287-1289.
5. Lewin KJ, Appelman HD Carcinoma of the stomach: Tumors of the esophagus and stomach. Atlas of Tumor Pathology (Third Series Fascicle 18) 1996, 245-9670. Armed Forces Institute of Pathology, Washington, DC.
6. Everett SM, Axon AT Early gastric cancer in Europe. Gut 1997, 41:142-150.
7. Folli S, Dente M, Dell'Amore D, et al. Early gastric cancer: Prognostic factors in 223 patients. Br J Surg 1995, 82:952-956.
8. Hisamichi S Screening for gastric cancer. World J Surg 1989, 13:31-37.
9. Sue-Ling HM, Martin I, Griffith J, et al. Early gastric cancer: 46 cases treated in one surgical department. Gut 1992, 33:1318-1322.
10. Correa P Human gastric carcinogenesis: A multistep and multifactorial process: First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992, 52:6735-6740.
11. Filipe MI, Munoz N, Matko I, et al. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia. Int J Cancer 1994, 57:324-329.
12. Hattori T, Sugihara H The pathological sequence in the development of gastric cancer: I. Scand J Gastroenterol Suppl 1996, 214:34-35.
13. Correa P A human model of gastric carcinogenesis. Cancer Res 1988, 48:3554-3560.
14. Howson CP, Hiyama T, Wynder EL The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986, 8:1-27.
15. Parkin DM, Laara E, Muir CS Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988, 41:184-197.
16. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 345:1525-1528.
17. Siurala M, Sipponen P, Kekki M Chronic gastritis: Dynamic and clinical aspects. Scand J Gastroenterol Suppl 1985, 109:69-76.
18. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 1991, 302:1302-1305.
19. Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991, 325:1132-1136.
20. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991, 325:1127-1131.
21. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa. Gastroenterology 2000, 118:661-669.
22. Gologan A, Graham DY, Sepulveda AR Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med 2005, 25:197-222.
23. Beales IL, Davey NJ, Pusey CD, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995, 346:381-382.
24. Goodman KJ Nutritional factors and Helicobacter pylori infection in Colombian children. J Pediatr Gastroenterol Nutr 1997, 25:507-515.
25. Correa P Diet modification and gastric cancer prevention. J Natl Cancer Inst Monogr 1992, 12:75-78.
26. Kikugawa K, Kato T, Takeda Y Formation of a highly mutagenic diazo compound from the bamethan-nitrite reaction. Mutat Res 1987, 177:35-43.
27. Mirvish SS, Grandjean AC, Moller H, et al. N-nitrosoproline excretion by rural Nebraskans drinking water of varied nitrate content. Cancer Epidemiol Biomarkers Prev 1992, 1:455-461.
28. Houghton PW, Mortensen NJ, Thomas WE, et al. Intragastric bile acids and histological changes in gastric mucosa. Br J Surg 1986, 73:354-356.
29. El-Omar EM The importance of interleukin 1? in Helicobacter pylori associated disease. Gut 2001, 48:743-747.
30. Munoz N, Matko I Histological types of gastric cancer and its relationship with intestinal metaplasia. Recent Results Cancer Res 1972, 39:99-105.
31. Nomizu T, Watanabe I Clinical investigation of familial clustering of cancer. Gan No Rinsho 1986, 32:485-492.
32. Correa P A human model of gastric carcinogenesis. Cancer Res 1988, 48:3554-3560.
33. Correa P Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol 1985, 12:2-10.
34. Jass JR A classification of gastric dysplasia. Histopathology 1983, 7:181-193.
35. Ghandur-Mnaymneh L, Paz J, Roldan E, et al. Dysplasia of nonmetaplastic gastric mucosa: A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol 1988, 12:96-114.
36. Siewert JR, Stein HJ Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998, 85:1457-1459.
37. Bosch A, Frias Z, Caldwell WL Adenocarcinoma of the esophagus. Cancer 1979, 43:1557-1561.
38. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: Is it different from that in the West?. Cancer 2000, 89:2555-2559.
39. Allum WH, Powell DJ, McConkey CC, et al. Gastric cancer: A 25-year review. Br J Surg 1989, 76:535-540.
40. Morales TG Adenocarcinoma of the gastric cardia. Dig Dis 1997, 15:346-356.
41. Cameron AJ, Lomboy CT, Pera M, et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995, 109:1541-1546.
42. Clark GW, Smyrk TC, Burdiles P, et al. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?. Arch Surg 1994, 129:609-614.
43. Wijnhoven BP, Siersema PD, Hop WC, et al. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity: Rotterdam Oesophageal Tumour Study Group. Br J Surg 1999, 86:529-535.
44. Kalish RJ, Clancy PE, Orringer MB, et al. Clinical, epidemiologic, and morphologic comparison between adenocarcinomas arising in Barrett's esophageal mucosa and in the gastric cardia. Gastroenterology 1984, 86:461-467.
45. Brown LM, Swanson CA, Gridley G, et al. Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer Inst 1995, 87:104-109.
46. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998, 90:150-155.
47. Lagergren J, Bergstrom R, Nyren O Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999, 130:883-890.
48. Morales TG, Bhattacharyya A, Johnson C, et al. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?. Am J Gastroenterol 1997, 92:1818-1822.
49. Hackelsberger A, Gunther T, Schultze V, et al. Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease?. Gut 1998, 43:17-21.
50. Morales TG, Bhattacharyya A, Camargo E, et al. Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia. Gastrointest Endosc 1998, 48:26-31.
51. Sharma P, Weston AP, Morales T, et al. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia. Gut 2000, 46:9-13.
52. Trudgill NJ, Suvarna SK, Kapur KC, et al. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997, 41:585-589.
53. Goldstein NS, Karim R Gastric cardia inflammation and intestinal metaplasia: Associations with reflux esophagitis and Helicobacter pylori. Mod Pathol 1999, 12:1017-1024.
54. Morales TG, Sampliner RE, Bhattacharyya A Intestinal metaplasia of the gastric cardia. Am J Gastroenterol 1997, 92:414-418.
55. Ruol A, Parenti A, Zaninotto G, et al. Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000, 88:2520-2528.
56. Fujita S Biology of early gastric carcinoma. Pathol Res Pract 1978, 163:297-309.
57. Eckardt VF, Giessler W, Kanzler G, et al. Clinical and morphological characteristics of early gastric cancer: A case-control study. Gastroenterology 1990, 98:708-714.
58. Farley DR, Donohue JH Early gastric cancer. Surg Clin North Am 1992, 72:401-421.
59. Craanen ME, Dekker W, Ferwerda J, et al. Early gastric cancer: A clinicopathologic study. J Clin Gastroenterol 1991, 13:274-283.
60. Ming SC, Hirota T Malignant epithelial tumors of the stomach. Pathology of the Gastrointestinal Tract 1998, 584-9391. Williams and Wilkins, Baltimore. S.C. Ming, H. Goldman (Eds.).
61. Marrano D, Viti G, Grigioni W, et al. Synchronous and metachronous cancer of the stomach. Eur J Surg Oncol 1987, 13:493-498.
62. Japanese Research Society for Gastric Cancer Group classification of gastric biopsy specimens. Japanese Classification of Gastric Carcinoma 1995, 74-924. Kanehara, Tokyo. M. Nishi, Y. Omori, K. Miwa (Eds.).
63. Xuan ZX, Ueyama T, Yao T, et al. Time trends of early gastric carcinoma: A clinicopathologic analysis of 2846 cases. Cancer 1993, 72:2889-2894.
64. Kurihara M, Shirakabe H, Yarita T, et al. Diagnosis of small early gastric cancer by x-ray, endoscopy, and biopsy. Cancer Detect Prev 1981, 4:377-383.
65. Blackstone MO Endoscopic Interpretation: Normal and Pathologic Appearances of the Gastrointestinal Tract 1984, Raven Press, New York.
66. Kobayashi S, Kasugai T, Yamazaki H Endoscopic differentiation of early gastric cancer from benign peptic ulcer. Gastrointest Endosc 1979, 25:55-57.
67. Kodama Y, Inokuchi K, Soejima K, et al. Growth patterns and prognosis in early gastric carcinoma: Superficially spreading and penetrating growth types. Cancer 1983, 51:320-326.
68. Oohara T, Tohma H, Takezoe K, et al. Minute gastric cancers less than 5 mm in diameter. Cancer 1982, 50:801-810.
69. Yoshida K, Manabe T, Tsunoda T, et al. Early gastric cancer of adenosquamous carcinoma type: Report of a case and review of literature. Jpn J Clin Oncol 1996, 26:252-257.
70. Tsukuma H, Mishima T, Oshima A Prospective study of "early" gastric cancer. Int J Cancer 1983, 31:421-426.
71. Itoh H, Oohata Y, Nakamura K, et al. Complete ten-year postgastrectomy follow-up of early gastric cancer. Am J Surg 1989, 158:14-16.
72. Maehara Y, Orita H, Okuyama T, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992, 79:245-247.
73. Yasuda K, Shiraishi N, Suematsu T, et al. Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma. Cancer 1999, 85:2119-2123.
74. Hiki Y, Shimao H, Mieno H, et al. Modified treatment of early gastric cancer: Evaluation of endoscopic treatment of early gastric cancers with respect to treatment indication groups. World J Surg 1995, 19:517-522.
75. Noda M, Kodama T, Atsumi M, et al. Possibilities and limitations of endoscopic resection for early gastric cancer. Endoscopy 1997, 29:361-365.
76. Yasuda K Endoscopic ultrasonic probes and mucosectomy for early gastric carcinoma. Gastrointest Endosc 1996, 43:S29-S31.
77. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997, 6:639-642.
78. Hundahl SA, Phillips JL, Menck HR The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 2000, 88:921-932.
79. Kodera Y, Yamamura Y, Torii A, et al. Incidence, diagnosis and significance of multiple gastric cancer. Br J Surg 1995, 82:1540-1543.
80. Borrmann R Geshwulste des Magens und Duodenums. Handbuch der Speziellen Patho-logischen Anatomie und Histologie 1926, 865. Springer-Verlag, Berlin. F. Henke, O. Lubarsch (Eds.).
81. Fiocca R, Villani L, Tenti P, et al. The foveolar cell component of gastric cancer. Hum Pathol 1990, 21:260-270.
82. Fiocca R, Villani L, Tenti P, et al. Characterization of four main cell types in gastric cancer: Foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours. Pathol Res Pract 1987, 182:308-325.
83. Chan WY, Hui PK, Leung KM, et al. Gastric adenocarcinoma with ciliated tumor cells. Hum Pathol 1993, 24:1107-1113.
84. Endoh Y, Tamura G, Motoyama T, et al. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999, 30:826-832.
85. Machado JC, Nogueira AM, Carneiro F, et al. Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000, 190:437-443.
86. Ming SC Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review. Gastric Cancer 1998, 1:31-50.
87. Takubo K The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy 2005, 12. Springer-Verlag, Tokyo. M. Kaminiski, K. Takubo, K. Mafune (Eds.).
88. Yokozaki H, Hasuo T, Li D, et al. Adenocarcinoma with gastric mucin phenotype. The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy 2005, 169-9819. Springer-Verlag, Tokyo. M. Kaminiski, K. Takubo, K. Mafune (Eds.).
89. Laurén P The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965, 64:31-49.
90. Cimerman M, Repse S, Jelenc F, et al. Comparison of Lauren's, Ming's and WHO histological classifications of gastric cancer as a prognostic factor for operated patients. Int Surg 1994, 79:27-32.
91. Uefuji K, Ichikura T, Tamakuma S Clinical and prognostic characteristics of papillary clear carcinoma of stomach. Surg Today 1996, 26:158-163.
92. Yasuda K, Adachi Y, Shiraishi N, et al. Papillary adenocarcinoma of the stomach. Gastric Cancer 2000, 3:33-38.
93. Hirota T, Itabashi M, Maruyama K Significance of the histological type of gastric carcinoma as a prognostic factor. Stomach Intestine 1991, 26:1149-1158.
94. Correa P, Tahara E Stomach. Pathology of Incipient Neoplasia 1993, WB Saunders, Philadelphia. D. Henson, J. Albores-Saavedra (Eds.).
95. Lauwers GY, Riddell RH Gastric epithelial dysplasia. Gut 1999, 45:784-790.
96. Murayama H, Imai T, Kikuchi M Solid carcinomas of the stomach: A combined histochemical, light and electron microscopic study. Cancer 1983, 51:1673-1681.
97. Ming S-C Gastric carcinoma: A pathobiological classification. Cancer 1977, 39:2475-2485.
98. Goseki N, Takizawa T, Koike M Differences in the mode of the extension of gastric cancer classified by histological type: New histological classification of gastric carcinoma. Gut 1992, 33:606-612.
99. Songun I, van de Velde CJ, Arends JW, et al. Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer 1999, 85:2114-2118.
100. Matsunou H, Konishi F, Hori H, et al. Characteristics of Epstein-Barr virus-associated gastric carcinoma with lymphoid stroma in Japan. Cancer 1996, 77:1998-2004.
101. Herrera-Goepfert R, Reyes E, Hernandez-Avila M, et al. Epstein-Barr virus-associated gastric carcinoma in Mexico: Analysis of 135 consecutive gastrectomies in two hospitals. Mod Pathol 1999, 12:873-878.
102. zur Hausen A, van Grieken NC, Meijer GA, et al. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. Gastroenterology 2001, 121:612-618.
103. Wang HH, Wu MS, Shun CT, et al. Lymphoepithelioma-like carcinoma of the stomach: A subset of gastric carcinoma with distinct clinicopathological features and high prevalence of Epstein-Barr virus infection. Hepatogastroenterology 1999, 46:1214-1219.
104. Watanabe H, Enjoji M, Imai T Gastric carcinoma with lymphoid stroma: Its morphologic characteristics and prognostic correlations. Cancer 1976, 38:232-243.
105. Nakamura S, Ueki T, Yao T, et al. Epstein-Barr virus in gastric carcinoma with lymphoid stroma: Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 1994, 73:2239-2249.
106. Yamamoto N, Tokunaga M, Uemura Y, et al. Epstein-Barr virus and gastric remnant cancer. Cancer 1994, 74:805-809.
107. Fukayama M, Chong JM, Kaizaki Y Epstein-Barr virus and gastric carcinoma. Gastric Cancer 1998, 1:104-111.
108. Gulley ML, Pulitzer DR, Eagan PA, et al. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 1996, 27:20-27.
109. Kang GH, Lee S, Kim WH, et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 2002, 160:787-794.
110. dos Santos NR, Seruca R, Constancia M, et al. Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis. Gastroenterology 1996, 110:38-44.
111. Inagawa S, Shimazaki J, Hori M, et al. Hepatoid adenocarcinoma of the stomach. Gastric Cancer 2001, 4:43-52.
112. Ishikura H, Kirişoto K, Shamoto M, et al. Hepatoid adenocarcinomas of the stomach: An analysis of seven cases. Cancer 1986, 58:119-126.
113. Motoyama T, Aizawa K, Watanabe H, et al. ?-Fetoprotein producing gastric carcinomas: A comparative study of three different subtypes. Acta Pathol Jpn 1993, 43:654-661.
114. Terracciano LM, Glatz K, Mhawech P, et al. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: An immunohistochemical and molecular study of eight cases. Am J Surg Pathol 2003, 27:1302-1312.
115. Kodama T, Kameya T, Hirota T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: Histologic and immunohistochemical analyses of 35 cases. Cancer 1981, 48:1647-1655.
116. Namatame K, Ookubo M, Suzuki K, et al. A clinicopathological study of five cases of adenosquamous carcinoma of the stomach [in Japanese]. Gan No Rinsho 1986, 32:170-175.
117. Mori M, Iwashita A, Enjoji M Adenosquamous carcinoma of the stomach: A clinicopathologic analysis of 28 cases. Cancer 1986, 57:333-339.
118. Ikeda E, Shigematsu T, Hidaka K, et al. A case of adenosquamous gastric carcinoma successfully treated with TS-1, low-dose CDDP and docetaxel as neoadjuvant chemotherapy [in Japanese]. Gan To Kagaku Ryoho 2007, 34:423-426.
119. Marubashi S, Yano H, Monden T, et al. Primary squamous cell carcinoma of the stomach. Gastric Cancer 1999, 2:136-141.
120. Won OH, Farman J, Krishnan MN, et al. Squamous cell carcinoma of the stomach. Am J Gastroenterol 1978, 69:594-598.
121. Takita J, Kato H, Miyazaki T, et al. Primary squamous cell carcinoma of the stomach: A case report with immunohistochemical and molecular biologic studies. Hepatogastroenterology 2005, 52:969-974.
122. Yildirim Y, Akcali Z, Bilezikci B, et al. Primary squamous cell carcinoma of the stomach: A case report. Tumori 2005, 91:440-442.
123. Wurzel J, Brooks JJ Primary gastric choriocarcinoma: Immunohistochemistry, postmortem documentation, and hormonal effects in a postmenopausal female. Cancer 1981, 48:2756-2761.
124. Garcia RL, Ghali VS Gastric choriocarcinoma and yolk sac tumor in a man: Observations about its possible origin. Hum Pathol 1985, 16:955-958.
125. Kanai M, Torii A, Hamada A, et al. Pure gastric yolk sac tumor that was diagnosed after curative resection: Case report and review of literature. Int J Gastrointest Cancer 2005, 35:77-81.
126. Imai Y, Kawabe T, Takahashi M, et al. A case of primary gastric choriocarcinoma and a review of the Japanese literature. J Gastroenterol 1994, 29:642-646.
127. Saigo PE, Brigati DJ, Sternberg SS, et al. Primary gastric choriocarcinoma: An immunohistological study. Am J Surg Pathol 1981, 5:333-342.
128. Jindrak K, Bochetto JF, Alpert LI Primary gastric choriocarcinoma: Case report with review of world literature. Hum Pathol 1976, 7:595-604.
129. Liu Z, Mira JL, Cruz-Caudillo JC Primary gastric choriocarcinoma: A case report and review of the literature. Arch Pathol Lab Med 2001, 125:1601-1604.
130. Cho KJ, Myong NH, Choi DW, et al. Carcinosarcoma of the stomach: A case report with light microscopic, immunohistochemical, and electron microscopic study. APMIS 1990, 98:991-995.
131. Nakayama Y, Murayama H, Iwasaki H, et al. Gastric carcinosarcoma (sarcomatoid carcinoma) with rhabdomyoblastic and osteoblastic differentiation. Pathol Int 1997, 47:557-563.
132. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
133. Sato Y, Shimozono T, Kawano S, et al. Gastric carcinosarcoma, coexistence of adenosquamous carcinoma and rhabdomyosarcoma: A case report. Histopathology 2001, 39:543-544.
134. Tsuneyama K, Sasaki M, Sabit A, et al. A case report of gastric carcinosarcoma with rhabdomyosarcomatous and neuroendocrinal differentiation. Pathol Res Pract 1999, 195:93-97.
135. Yamazaki K A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma: An immunohistochemical and ultrastructural study. Virchows Arch 2003, 442:77-81.
136. Ikeda Y, Kosugi S, Nishikura K, et al. Gastric carcinosarcoma presenting as a huge epigastric mass. Gastric Cancer 2007, 10:63-68.
137. Kallakury BV, Bui HX, delRosario A, et al. Primary gastric adenosarcoma. Arch Pathol Lab Med 1993, 117:299-301.
138. Namikawa T, Kobayashi M, Okabayashi T, et al. Primary gastric small cell carcinoma: Report of a case and review of the literature. Med Mol Morphol 2005, 38:256-261.
139. Hussein AM, Otrakji CL, Hussein BT Small cell carcinoma of the stomach: Case report and review of the literature. Dig Dis Sci 1990, 35:513-518.
140. Takaku H, Oka K, Naoi Y, et al. Primary advanced gastric small cell carcinoma: A case report and review of the literature. Am J Gastroenterol 1999, 94:1402-1404.
141. Yata Y, Nakayama Y, Takahara T, et al. A case of small cell gastric carcinoma with an adenocarcinoma component operated curatively. Acta Med Okayama 2004, 58:275-278.
142. Kusayanagi S, Konishi K, Miyasaka N, et al. Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol 2003, 18:743-747.
143. Matsubayashi H, Takagaki S, Otsubo T, et al. Advanced gastric glandular-endocrine cell carcinoma with 1-year survival after gastrectomy. Gastric Cancer 2000, 3:226-233.
144. Byrne D, Holley MP, Cuschieri A Parietal cell carcinoma of the stomach: Association with long-term survival after curative resection. Br J Cancer 1988, 58:85-87.
145. Capella C, Frigerio B, Cornaggia M, et al. Gastric parietal cell carcinoma-a newly recognized entity: Light microscopic and ultrastructural features. Histopathology 1984, 8:813-824.
146. Kazzaz BA, Eulderink F Paneth cell-rich carcinoma of the stomach. Histopathology 1989, 15:303-305.
147. Ooi A, Nakanishi I, Itoh T, et al. Predominant Paneth cell differentiation in an intestinal type gastric cancer. Pathol Res Pract 1991, 187:220-225.
148. Yang GY, Liao J, Cassai ND, et al. Parietal cell carcinoma of gastric cardia: Immunophenotype and ultrastructure. Ultrastruct Pathol 2003, 27:87-94.
149. Takubo K, Honma N, Sawabe M, et al. Oncocytic adenocarcinoma of the stomach: Parietal cell carcinoma. Am J Surg Pathol 2002, 26:458-465.
150. Cremer H, Joneleit V, Seyfarth KA, et al. Mucoepidermoid carcinoma of the stomach [in German]. Leber Magen Darm 1985, 15:148-151.
151. Hayashi I, Muto Y, Fujii Y, et al. Mucoepidermoid carcinoma of the stomach. J Surg Oncol 1987, 34:94-99.
152. Rivera-Hueto F, Rios-Martin JJ, Dominguez-Triano R, et al. Early gastric stump carcinoma with rhabdoid features: Case report. Pathol Res Pract 1999, 195:841-846.
153. Ueyama T, Nagai E, Yao T, et al. Vimentin-positive gastric carcinomas with rhabdoid features: A clinicopathologic and immunohistochemical study. Am J Surg Pathol 1993, 17:813-819.
154. Pinto JA, Gonzalez Alfonso JE, Gonzalez L, et al. Well differentiated gastric adenocarcinoma with rhabdoid areas: A case report with immunohistochemical analysis. Pathol Res Pract 1997, 193:801-805.
155. Niederau C, Sobin LH Secondary tumors of the stomach. World Health Organization Classification of Tumour: Pathology and Genetics of Tumours of the Digestive System 2000, 66-933. IARC Press, Lyon, France. S.R. Hamilton, L.A. Aaltonen (Eds.).
156. Oda I, Kondo H, Yamao T, et al. Metastatic tumors to the stomach: Analysis of 54 patients diagnosed at endoscopy and 347 autopsy cases. Endoscopy 2001, 33:507-510.
157. Alpar S, Kurt OK, Ucar N, et al. A case of squamous cell lung carcinoma with gastric metastasis. South Med J 2006, 99:1313-1314.
158. Green LK Hematogenous metastases to the stomach: A review of 67 cases. Cancer 1990, 65:1596-1600.
159. Taal BG, Peterse H, Boot H Clinical presentation, endoscopic features, and treatment of gastric metastases from breast carcinoma. Cancer 2000, 89:2214-2221.
160. Campoli PM, Ejima FH, Cardoso DM, et al. Metastatic cancer to the stomach. Gastric Cancer 2006, 9:19-25.
161. O'Connell FP, Wang HH, Odze RD Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract. Arch Pathol Lab Med 2005, 129:338-347.
162. Shimizu M, Matsumoto T, Hirokawa M, et al. Gastric metastasis from breast cancer: A pitfall in gastric biopsy specimens. Pathol Int 1998, 48:240-241.
163. Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 1995, 3:99-107.
164. Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 2004, 17:1392-1399.
165. Lau SK, Weiss LM, Chu PG Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: An immunohistochemical study. Am J Clin Pathol 2004, 122:61-69.
166. Safatle-Ribeiro AV, Ribeiro U, Reynolds JC Gastric stump cancer: What is the risk?. Dig Dis 1998, 16:159-168.
167. Toftgaard C Gastric cancer after peptic ulcer surgery: A historic prospective cohort investigation. Ann Surg 1989, 210:159-164.
168. MacDonald WC, Owen DA Gastric carcinoma after surgical treatment of peptic ulcer: An analysis of morphologic features and a comparison with cancer in the nonoperated stomach. Cancer 2001, 91:1732-1738.
169. Kaminishi M, Shimizu N, Yamaguchi H, et al. Different carcinogenesis in the gastric remnant after gastrectomy for gastric cancer. Cancer 1996, 77:1646-1653.
170. Taylor PR, Mason RC, Filipe MI, et al. Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: Morphology, mucin histochemistry, polyamine metabolism, and labelling index. Gut 1991, 32:1447-1454.
171. Offerhaus GJ, van de Stadt J, Huibregtse K, et al. The mucosa of the gastric remnant harboring malignancy: Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions. Cancer 1989, 64:698-703.
172. Stael von Holstein C, Hammar E, Eriksson S, et al. Clinical significance of dysplasia in gastric remnant biopsy specimens. Cancer 1993, 72:1532-1535.
173. Kaizaki Y, Hosokawa O, Sakurai S, et al. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: De novo and metachronous gastric remnant carcinoma. J Gastroenterol 2005, 40:570-577.
174. Ikeguchi M, Kondou A, Shibata S, et al. Clinicopathologic differences between carcinoma in the gastric remnant stump after distal partial gastrectomy for benign gastroduodenal lesions and primary carcinoma in the upper third of the stomach. Cancer 1994, 73:15-21.
175. Koea JB, Karpeh MS, Brennan MF Gastric cancer in young patients: Demographic, clinicopathological, and prognostic factors in 92 patients. Ann Surg Oncol 2000, 7:346-351.
176. Kokkola A, Sipponen P Gastric carcinoma in young adults. Hepatogastroenterology 2001, 48:1552-1555.
177. Rugge M, Busatto G, Cassaro M, et al. Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer 1999, 85:2506-2511.
178. Buffart TE, Carvalho B, Hopmans E, et al. Gastric cancers in young and elderly patients show different genomic profiles. J Pathol 2007, 211:45-51.
179. Chung DC, Yoon SS, Lauwers GY, et al. Case records of the Massachusetts General Hospital. Case 22-2007: A woman with a family history of gastric and breast cancer. N Engl J Med 2007, 357:283-291.
180. Gayther SA, Gorringe KL, Ramus SJ, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998, 58:4086-4089.
181. Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402-405.
182. Guilford PJ, Hopkins JB, Grady WM, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999, 14:249-255.
183. Keller G, Vogelsang H, Becker I, et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 1999, 155:337-342.
184. Blair V, Martin I, Shaw D, et al. Hereditary diffuse gastric cancer: Diagnosis and management. Clin Gastroenterol Hepatol 2006, 4:262-275.
185. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: Overview and guidelines for management. J Med Genet 1999, 36:873-880.
186. Pharoah PD, Guilford P, Caldas C Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001, 121:1348-1353.
187. Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001, 344:1904-1909.
188. Aarnio M, Salovaara R, Aaltonen LA, et al. Features of gastric cancer in hereditary non-polyposis colorectal cancer syndrome. Int J Cancer 1997, 74:551-555.
189. Chung DC, Rustgi AK The hereditary nonpolyposis colorectal cancer syndrome: Genetics and clinical implications. Ann Intern Med 2003, 138:560-570.
190. Mecklin JP, Jarvinen HJ, Peltokallio P Cancer family syndrome: Genetic analysis of 22 Finnish kindreds. Gastroenterology 1986, 90:328-333.
191. Park YJ, Shin KH, Park JG Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea. Clin Cancer Res 2000, 6:2994-2998.
192. Abraham SC, Nobukawa B, Giardiello FM, et al. Fundic gland polyps in familial adenomatous polyposis: Neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 2000, 157:747-754.
193. Hofgartner WT, Thorp M, Ramus MW, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 1999, 94:2275-2281.
194. Offerhaus GJ, Entius MM, Giardiello FM Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 1999, 46:667-669.
195. Watanabe H, Enjoji M, Yao T, et al. Gastric lesions in familial adenomatosis coli: Their incidence and histologic analysis. Hum Pathol 1978, 9:269-283.
196. Zwick A, Munir M, Ryan CK, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 1997, 113:659-663.
197. Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: Intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002, 26:1276-1285.
198. Kimura K, Shinmura K, Hasegawa T, et al. Germline p53 mutation in a patient with multiple primary cancers. Jpn J Clin Oncol 2001, 31:349-351.
199. Kleihues P, Schauble B, zur Hausen A, et al. Tumors associated with p53 germline mutations: A synopsis of 91 families. Am J Pathol 1997, 150:1-13.
200. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000, 119:1447-1453.
201. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998, 18:38-43.
202. Carneiro F, David L, Seruca R, et al. Hyperplastic polyposis and diffuse carcinoma of the stomach: A study of a family. Cancer 1993, 72:323-329.
203. Seruca R, Carneiro F, Castedo S, et al. Familial gastric polyposis revisited: Autosomal dominant inheritance confirmed. Cancer Genet
204. Niv Y, Delpre G, Sperber AD, et al. Hyperplastic gastric polyposis, hypergastrinaemia and colorectal neoplasia: A description of four cases. Eur J Gastroenterol Hepatol 2003, 15:1361-1366.
205. Esaki Y, Hirayama R, Hirokawa K A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 1990, 65:2086-2090.
206. Mori M, Sakaguchi H, Akazawa K, et al. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol 1995, 26:504-508.
207. Carneiro F, Seixas M, Sobrinho-Simoes M New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 1995, 191:571-584.
208. Yoshikawa K, Maruyama K Characteristics of gastric cancer invading to the proper muscle layer with special reference to mortality and cause of death. Jpn J Clin Oncol 1985, 15:499-503.
209. AJCC Cancer Staging Manual 2002, Springer-Verlag, New York. F.L. Greene, D.L. Page, I.D. Fleming (Eds.).
210. Hermanek P The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer 2000, 88:1763-1765.
211. Hermanek P, Altendorf-Hofmann A, Mansmann U, et al. Improvements in staging of gastric carcinoma from using the new edition of TNM classification. Eur J Surg Oncol 1998, 24:536-541.
212. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004, 54:8-29.
213. Karpeh MS, Brennan MF Gastric carcinoma. Ann Surg Oncol 1998, 5:650-656.
214. Fujii M, Sasaki J, Nakajima T State of the art in the treatment of gastric cancer: From the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999, 2:151-157.
215. Sasako M Principles of surgical treatment for curable gastric cancer. J Clin Oncol 2003, 21:274s-275s.
216. Cunningham SC, Kamangar F, Kim MP, et al. Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution. J Gastrointest Surg 2005, 9:718-725.
217. Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States?. Cancer 2000, 89:2237-2246.
218. Saito H, Fukumoto Y, Osaki T, et al. Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach. World J Surg 2006, 30:1864-1869.
219. Roder JD, Bottcher K, Busch R, et al. Classification of regional lymph node metastasis from gastric carcinoma: German Gastric Cancer Study Group. Cancer 1998, 82:621-631.
220. Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 1993, 218:583-592.
221. Karpeh MS, Leon L, Klimstra D, et al. Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients. Ann Surg 2000, 232:362-371.
222. Landry J, Tepper JE, Wood WC, et al. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990, 19:1357-1362.
223. Bunt AM, Hermans J, Smit VT, et al. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995, 13:19-25.
224. Roukos DH, Kappas AM Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 2002, 81:59-62. discussion 62.
225. Birkmyer J, Siewers A, Finlayson E, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-1137.
226. Correa P, Shiao YH Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994, 54:1941s-1943s.
227. Fuchs CS, Mayer RJ Gastric carcinoma. N Engl J Med 1995, 333:32-41.
228. Stemmermann GN Intestinal metaplasia of the stomach: A status report. Cancer 1994, 74:556-564.
229. Tahara E Genetic alterations in human gastrointestinal cancers: The application to molecular diagnosis. Cancer 1995, 75:1410-1417.
230. Wright PA, Williams GT Molecular biology and gastric carcinoma. Gut 1993, 34:145-147.
231. Brito MJ, Williams GT, Thompson H, et al. Expression of p53 in early (T1) gastric carcinoma and precancerous adjacent mucosa. Gut 1994, 35:1697-1700.
232. Milne AN, Carvalho R, Morsink FM, et al. Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol 2006, 19:564-572.
233. Lee JH, Abraham SC, Kim HS, et al. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002, 161:611-618.
234. Park K, Kim SJ, Bang YJ, et al. Genetic changes in the transforming growth factor ? (TGF-?) type II receptor gene in human gastric cancer cells: Correlation with sensitivity to growth inhibition by TGF-?. Proc Natl Acad Sci U S A 1994, 91:8772-8776.
235. Hara T, Ooi A, Kobayashi M, et al. Amplification of c-myc, K-sam, and c-met in gastric cancers: Detection by fluorescence in situ hybridization. Lab Invest 1998, 78:1143-1153.
236. Lee JH, Han SU, Cho H, et al. A novel germ line juxtamembrane Met mutation in human gastric cancer. Oncogene 2000, 19:4947-4953.
237. Hattori Y, Odagiri H, Nakatani H, et al. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A 1990, 87:5983-5987.
238. Wu MS, Lee CW, Shun CT, et al. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer 2000, 27:403-411.
239. Saukkonen K, Rintahaka J, Sivula A, et al. Cyclooxygenase-2 and gastric carcinogenesis. APMIS 2003, 111:915-925.
240. Lauwers GY, Scott GV, Karpeh MS Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995, 75:2209-2213.
241. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995, 55:2111-2115.
242. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997, 40:297-301.